Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$9.85 – $17.85
45% from low
Exchange
OTC Link
OS
ASTELLAS PHARMA INC
No one on the platform currently holds ALPMF.
No tracked institution reports a position in ALPMF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $40.0000 | |
| 2026-09-30 | $40.0000 | |
| 2026-03-31 | $39.0000 | 2026-06-03 |
| 2025-09-30 | $39.0000 | 2025-12-01 |
| 2025-03-31 | $37.0000 | 2025-06-03 |
| 2024-09-30 | $37.0000 | 2024-12-02 |
| 2024-03-28 | $35.0000 | 2024-06-03 |
| 2023-09-29 | $35.0000 | 2023-12-01 |
No one on the platform has traded ALPMF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $2.34T | +9.3% | $195.58 | $186.26–$209.96 | 0.1× | 2 |
| 2028 | $2.15T | -7.9% | $188.94 | $179.93–$202.82 | 0.1× | 3 |
| 2029 | $1.91T | -11.1% | $139.23 | $132.59–$149.46 | 0.1× | 3 |
| 2030 | $1.77T | -7.4% | $112.75 | $107.38–$121.04 | 0.1× | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-05 | $0.33 | $0.49 | +46.3% |
| 2026-04-27 | $0.19 | $0.15 | -20.6% |
| 2026-02-04 | $0.29 | $0.36 | +22.0% |
| 2025-10-30 | $0.20 | $0.30 | +48.3% |
| 2025-07-30 | $0.14 | $0.27 | +92.3% |
| 2025-04-25 | $0.14 | $0.28 | +96.3% |
| 2025-02-04 | $0.00 | $-0.35 | -35867.0% |
| 2024-10-30 | $0.15 |
| $0.13 |
| -11.2% |
| +0.00% |
| $13.8B |
| — |
| GIKLYGrifols, S.A. | $5.10 | +0.00% | $13.4B | — |
| GNMSFGenmab A/S | $310.63 | -0.28% | $19.1B | — |
Source: Financial Modeling Prep · peers by sector/industry